Hepatitis C in the HIV-Infected Person

Area of Science:

• Hepatology
• Virology
• Infectious Diseases

Background:

• Hepatitis C virus (HCV) infection is prevalent in persons with human immunodeficiency virus (HIV) due to shared transmission routes.
• Effective antiretroviral therapy for HIV has led to increased HCV-related morbidity and mortality.
• HIV infection adversely impacts HCV outcomes, including increased viral persistence and accelerated liver disease progression.

Purpose of the Study:

• To review the challenges and current understanding of managing HCV in HIV-infected individuals.
• To highlight the need for further research into the pathogenesis and optimal treatment strategies for HIV-HCV co-infection.

Main Methods:

• Literature review of existing studies on HIV-HCV co-infection.
• Analysis of the impact of HIV on HCV disease progression and treatment.
• Examination of management complexities, including immune suppression and drug interactions.

Main Results:

• HIV co-infection is associated with poorer HCV outcomes and accelerated liver disease.
• Management is complicated by immune status, potential drug toxicities, and interactions.
• Limited data exist on the safety and efficacy of anti-HCV medications in this population.

Conclusions:

• Preventing HCV and HIV infections is crucial.
• Applying knowledge from single-infection management to co-infected patients is necessary.
• Further prospective studies are essential to establish optimal management protocols for HIV-HCV co-infection to mitigate liver disease burden.